Submitted by Anonymous (not verified) on 12 January 2026 - 11:00
Human medicines European public assessment report (EPAR): Tremfya, guselkumab, Date of authorisation: 10/11/2017, Revision: 15, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Tremfya, guselkumab, Date of authorisation: 10/11/2017, Revision: 15, Status: Authorised